Search

Your search keyword '"Zekeridou, Anastasia"' showing total 18 results
Start Over Author "Zekeridou, Anastasia" Publisher wiley
18 results on '"Zekeridou, Anastasia"'

1. Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid

Author

Redenbaugh, Vyanka, primary, Fryer, James P., additional, Cacciaguerra, Laura, additional, Chen, John J., additional, Greenwood, Tammy M., additional, Gilligan, Michael, additional, Thakolwiboon, Smathorn, additional, Majed, Masoud, additional, Chia, Nicholas H, additional, McKeon, Andrew, additional, Mills, John R., additional, Lopez Chiriboga, A. Sebastian, additional, Tillema, Jan‐Mendelt, additional, Yang, Binxia, additional, Abdulrahman, Yahya, additional, Guo, Kai, additional, Vorasoot, Nisa, additional, Valencia Sanchez, Cristina, additional, Tajfirouz, Deena A., additional, Toledano, Michel, additional, Zekeridou, Anastasia, additional, Dubey, Divyanshu, additional, Gombolay, Grace Y, additional, Caparó‐Zamalloa, César, additional, Kister, Ilya, additional, Pittock, Sean J., additional, and Flanagan, Eoin P., additional

Published
2024
Full Text
View/download PDF

2. Detection of High‐Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins

Author

Bartley, Christopher M., primary, Ngo, Thomas T., additional, Do, Le Duy, additional, Zekeridou, Anastasia, additional, Dandekar, Ravi, additional, Muñiz‐Castrillo, Sergio, additional, Alvarenga, Bonny D., additional, Zorn, Kelsey C., additional, Tubati, Asritha, additional, Pinto, Anne‐Laurie, additional, Browne, Weston D., additional, Hullett, Patrick W., additional, Terrelonge, Mark, additional, Schubert, Ryan D., additional, Piquet, Amanda L., additional, Yang, Binxia, additional, Montalvo, Mayra, additional, Kung, Andrew F., additional, Mann, Sabrina A., additional, Shah, Maulik P., additional, Geschwind, Michael D., additional, Gelfand, Jeffrey M., additional, DeRisi, Joseph L., additional, Pittock, Sean J., additional, Honnorat, Jérôme, additional, Pleasure, Samuel J., additional, and Wilson, Michael R., additional

Published
2023
Full Text
View/download PDF

4. Seizure characteristics and outcomes in patients with neurological conditions related to high‐risk paraneoplastic antibodies

Author

Smith, Kelsey M., primary, Britton, Jeffrey W., additional, Thakolwiboon, Smathorn, additional, Chia, Nicholas H., additional, Gupta, Pranjal, additional, Flanagan, Eoin P., additional, Zekeridou, Anastasia, additional, Lopez Chiriboga, Alfonso S., additional, Valencia Sanchez, Cristina, additional, McKeon, Andrew, additional, Pittock, Sean J., additional, and Dubey, Divyanshu, additional

Published
2023
Full Text
View/download PDF

8. CASPR2‐IgG‐associated autoimmune seizures

Author

Garrido Sanabria, Emilio R., primary, Zahid, Anza, additional, Britton, Jeffrey, additional, Kraus, Gregory J., additional, López‐Chiriboga, Alfonso Sebastian, additional, Zekeridou, Anastasia, additional, Flanagan, Eoin P., additional, McKeon, Andrew, additional, Mills, John R., additional, Pittock, Sean J., additional, and Dubey, Divyanshu, additional

Published
2022
Full Text
View/download PDF

10. Seizures and memory impairment induced by patient‐derived anti‐N‐methyl‐D‐aspartate receptor antibodies in mice are attenuated by anakinra, an interleukin‐1 receptor antagonist

Author

Taraschenko, Olga, primary, Fox, Howard S., additional, Zekeridou, Anastasia, additional, Pittock, Sean J., additional, Eldridge, Ember, additional, Farukhuddin, Fnu, additional, Al‐Saleem, Fetweh, additional, Devi Kattala, Chandana, additional, Dessain, Scott K., additional, Casale, George, additional, Willcockson, Gregory, additional, and Dingledine, Raymond, additional

Published
2021
Full Text
View/download PDF

11. Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers

Author

McKeon, Andrew, primary, Shelly, Shahar, additional, Zivelonghi, Cecilia, additional, Basal, Eati, additional, Dubey, Divyanshu, additional, Flanagan, Eoin, additional, Madhavan, Ajay A., additional, Mariotto, Sara, additional, Toledano, Michel, additional, Tracy, Jennifer A., additional, Zekeridou, Anastasia, additional, and Pittock, Sean J., additional

Published
2020
Full Text
View/download PDF

12. Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy

Author

Dubey, Divyanshu, primary, Britton, Jeffrey, additional, McKeon, Andrew, additional, Gadoth, Avi, additional, Zekeridou, Anastasia, additional, Lopez Chiriboga, Sebastian A., additional, Devine, Michelle, additional, Cerhan, Jane H., additional, Dunlay, Katie, additional, Sagen, Jessica, additional, Ramberger, Melanie, additional, Waters, Patrick, additional, Irani, Sarosh R., additional, and Pittock, Sean J., additional

Published
2019
Full Text
View/download PDF

15. LGI1 and CASPR2 neurological autoimmunity in children

Author

López-Chiriboga, A. Sebastian, primary, Klein, Christopher, additional, Zekeridou, Anastasia, additional, McKeon, Andrew, additional, Dubey, Divyanshu, additional, Flanagan, Eoin P., additional, Lennon, Vanda A., additional, Tillema, Jan-Mendelt, additional, Wirrell, Elaine C., additional, Patterson, Marc C., additional, Gadoth, Avi, additional, Aaen, J. Gregory, additional, Brenton, J. Nicholas, additional, Bui, Jonathan D., additional, Moen, Amanda, additional, Otten, Catherine, additional, Piquet, Amanda, additional, and Pittock, Sean J., additional

Published
2018
Full Text
View/download PDF

17. Elevated LGI1-IgG CSF index predicts worse neurological outcome

Author

Gadoth, Avi, primary, Zekeridou, Anastasia, additional, Klein, Christopher J., additional, Thoreson, Colton J., additional, Majed, Masoud, additional, Dubey, Divyanshu, additional, Flanagan, Eoin P., additional, McKeon, Andrew, additional, Jenkins, Sarah M., additional, Lennon, Vanda A., additional, and Pittock, Sean J., additional

Published
2018
Full Text
View/download PDF

18. Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles.

Author

Mangioris G, Halfdanarson TR, Lennon VA, Chang BK, Dubey D, Dyck PJB, Flanagan EP, McKeon A, Mills JR, Pittock SJ, and Zekeridou A

Subjects
Humans, Male, Female, Aged, Middle Aged, Adult, Aged, 80 and over, Retrospective Studies, Autoimmunity immunology, Paraneoplastic Syndromes, Nervous System immunology, Paraneoplastic Syndromes, Nervous System blood, Autoimmune Diseases of the Nervous System immunology, Autoimmune Diseases of the Nervous System blood, Autoantibodies blood, Autoantibodies immunology, Neuroendocrine Tumors immunology, Neuroendocrine Tumors complications
Abstract

Background and Purpose: Paraneoplastic neurological autoimmunity is well described with small-cell lung cancer, but information is limited for other neuroendocrine neoplasms (NENs)., Methods: Adult patients with histopathologically confirmed non-pulmonary NENs, neurological autoimmunity within 5 years of NEN diagnosis, and neural antibody testing performed at the Mayo Clinic Neuroimmunology Laboratory (January 2008 to March 2023) were retrospectively identified. Control sera were available from patients with NENs without neurological autoimmunity (116)., Results: Thirty-four patients were identified (median age 68 years, range 31-87). The most common primary tumor sites were pancreas (nine), skin (Merkel cell, eight), small bowel/duodenum (seven), and unknown (seven). Five patients received immune checkpoint inhibitor (ICI) therapy before symptom onset; symptoms preceded cancer diagnosis in 62.1% of non-ICI-treated patients. The most frequent neurological phenotypes (non-ICI-treated) were movement disorders (12; cerebellar ataxia in 10), dysautonomia (six), peripheral neuropathy (eight), encephalitis (four), and neuromuscular junction disorders (four). Neural antibodies were detected in 55.9% of patients studied (most common specificities: P/Q-type voltage-gated calcium channel [seven], muscle-type acetylcholine receptor [three], anti-neuronal nuclear antibody type 1 [three], and neuronal intermediate filaments [two]), but in only 6.9% of controls. Amongst patients receiving cancer or immunosuppressive therapy, 51.6% had partial or complete recovery. Outcomes were unfavorable in 48.3% (non-ICI-treated) and neural autoantibody positivity was associated with poor neurological outcome., Discussion: Neurological autoimmunity associated with non-pulmonary NENs is often multifocal and can be treatment responsive, underscoring the importance of rapid recognition and early treatment., (© 2024 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results